510(k) DEN190023

AmplideX Fragile X Dx & Carrier Screen Kit by Asuragen, Inc. — Product Code OYV

Clearance Details

Decision
DENG (De Novo Granted)
Decision Date
February 21, 2020
Date Received
April 18, 2019
Clearance Type
Direct
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Inherited Nucleotide Repeat Disorder Dna Test
Device Class
Class II
Regulation Number
866.5970
Review Panel
PA
Submission Type

An inherited nucleotide repeat disorder DNA test is a prescription in vitro diagnostic test that is intended to detect and identify the number of nucleotide repeats in a gene using genomic DNA isolated from post-natal patient specimens. It is solely intended as an aid for carrier testing and as an aid for the diagnosis of inherited nucleotide repeat-associated disorders. Assay results are solely intended to be used in conjunction with other clinical and diagnostic findings. These tests do not include those indicated for use for fetal diagnostic testing or newborn screening.